Please provide your email address to receive an email when new articles are posted on . Data were analyzed from 709 participants given ozanimod or interferon in two different trials trials. At 6 ...

There's good news for those with multiple sclerosis (MS). A new study has found that female participants were no more likely to have a flare-up of the disease after receiving fertility treatments than ...

A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...

Illustration showing demylination, a process in which the myelin sheath of neurons is damaged. This damage is seen in demyelinating diseases, such as multiple sclerosis and other demyelinating ...

The National Institute for Health and Care Excellence (NICE) has updated its guidance on the use of cladribine (Mavenclad, Merck) for patients with rapidly evolving severe relapsing-remitting multiple ...

that affects the central nervous system. There are various types of MS. Several of these are characterized by inflammation and damage due to demyelination and scarring in the central nervous system, ...

October 24, 2011 (Amsterdam, the Netherlands) — The full results of a phase 3 trial directly comparing alemtuzumab (Lemtrada, Genzyme) with interferon-beta-1a (Rebif, EMD Serono/Pfizer) show a ...

—Family planning is never an easy undertaking, but things take a turn when fertility is a problem and the woman has MS. The question then often becomes: Will IVF treatments raise the risk of a ...

Over one-third of MS patients do not fully recover post-relapse, with severity as the strongest predictor of incomplete recovery. Relapse-associated worsening (RAW) is crucial in understanding ...

Please provide your email address to receive an email when new articles are posted on . Two studies included 1,367 patients with MS who were given continuous Kesimpta or switched to Kesimpta. Kesimpta ...

Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...